Prescient Therapeutics (ASX: PTX)
Live Investor Briefing
Register for an Upcoming Webcast
Please join us for a special ‘OmniCAR Explainer’ session with Prescient Therapeutics CEO and MD Steven Yatomi-Clarke and Dr Rebecca Lim, Director of Scientific Affairs.
In the session, we will:
- Provide an overview into the amazing field of CAR-T, and how Prescient’s next gen CAR-T platform, OmniCAR, is seeking to take this burgeoning cancer field to the next level.
- Step through the new preclinical data, which demonstrates key OmniCAR features in next gen CAR-Ts, including control and flexibility which is not possible with current generation CAR-T therapies.
This is a live and interactive online session, and participants are encouraged to ask questions. Joining only requires an internet connection. Spots are limited, so secure yours today.